Clinical Trial Update: Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on treating HIV/HCV coinfection with Pegylated interferon and ribavirin in patients on lopinavir/ritonavir-based ART; study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)
• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: HIV/HCV Co-infection, HIV Infections | Phase 4 | Status: COMPLETED